ReadyGo Diagnostics Ltd. and Gemina Laboratories Ltd. have demonstrated the feasibility of using saliva as a sample for detecting Mycobacterium Tuberculosis (MTB). This development could revolutionise TB detection efforts, especially in countries where the disease is prevalent. The collaboration aims to develop a saliva-based MTB Screening Test using the Geo platform, providing quick and affordable results within 30 minutes, with plans for a compact laboratory instrument priced below $1000 and a per-test cost of $5.